2003
DOI: 10.1590/s0036-46652003000400005
|View full text |Cite
|
Sign up to set email alerts
|

Seroprevalence of antibodies to Venezuelan equine encephalitis complex (subtypes IAB and VI) in humans from General Belgrano Island, Formosa, Argentina

Abstract: SUMMARYThis work presents the results of the detection of antibodies (immunoglobulin G) for subtypes I and VI of VEE viruses complex (Togaviridae family) in people from the General Belgrano island, Formosa province (Argentina). The prevalence of neutralizing (NT) antibodies for subtype VI was from 30% to 70% and the prevalence of antibodies inhibitory of hemagglutination (HI) was of 0% in the first and second inquiry respectively. For the subtype IAB the prevalence of NT antibodies was from 13% to 3.6%, simila… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 11 publications
0
8
0
Order By: Relevance
“…In addition to providing opportunities for cross-reactivity, there is strong epidemiologic evidence linking many of these alphaviruses with human illness. [9][10][11][12][13][14][15][16][17][18][19][20] In addition, laboratory and epidemiologic observations have shown some cross-protection among alphaviruses, [21][22][23][24] although other studies contradict those find-ings. 25,26 In an attempt to resolve its role in alphaviral disease and epidemiology, we first assessed cross-protection in mice and hamsters first infected with VEEV and MAYV, the most prevalent alphaviruses infecting humans in the Amazon region of Peru, and challenged with EEEV.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to providing opportunities for cross-reactivity, there is strong epidemiologic evidence linking many of these alphaviruses with human illness. [9][10][11][12][13][14][15][16][17][18][19][20] In addition, laboratory and epidemiologic observations have shown some cross-protection among alphaviruses, [21][22][23][24] although other studies contradict those find-ings. 25,26 In an attempt to resolve its role in alphaviral disease and epidemiology, we first assessed cross-protection in mice and hamsters first infected with VEEV and MAYV, the most prevalent alphaviruses infecting humans in the Amazon region of Peru, and challenged with EEEV.…”
Section: Introductionmentioning
confidence: 99%
“…For arboviruses, PRNT is the gold standard technique due to its high sensitivity and specificity. In Argentina, there is serological evidence of the presence of VEEV since 1950's decade in humans and rodents [24], [21], [11]. Our studies detected current VEEV activity in the North part of the country.…”
Section: Discussionmentioning
confidence: 50%
“…This should be considered cautiously, since there is no evidence of epidemic/epizootic viral activity in our region, but the circulation of an enzootic variety of other subtype I might exist. This hypothesis was first proposed by Monath in 1985, and is supported by previous detections of antibodies against VEEV IAB in animals during the 80's [21] and in humans in 1991 [11], although no isolations of members of this subtype have been reported up to date. This leaves an open door to suspect that these antibodies previously detected could correspond to antibodies against PIXV captured by TC83 strain in the PRNT.…”
Section: Discussionmentioning
confidence: 59%
See 1 more Smart Citation
“…1999) (Figure 1). Serological studies indicate the presence of human antibodies against more than one enzootic subtype (I and VI) in subtropical regions of Argentina (Cámara et al. 2003).…”
mentioning
confidence: 99%